{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T15:02:17Z","timestamp":1787238137433,"version":"build-2736575974"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2017,3,10]],"date-time":"2017-03-10T00:00:00Z","timestamp":1489104000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1007\/s00415-017-8436-9","type":"journal-article","created":{"date-parts":[[2017,3,10]],"date-time":"2017-03-10T00:30:46Z","timestamp":1489105846000},"page":"2178-2183","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":48,"title":["Neurological complications of Beh\u00e7et\u2019s syndrome"],"prefix":"10.1007","volume":"264","author":[{"given":"D. P.","family":"Kidd","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,3,10]]},"reference":[{"key":"8436_CR1","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/ncprheum0436","volume":"3","author":"H Yazici","year":"2007","unstructured":"Yazici H, Fresko I, Yurdakul S (2007) Beh\u00e7et\u2019s syndrome: disease manifestations, management and advances in treatment. Nat Clin Pract Rheumatol 3:148\u2013155","journal-title":"Nat Clin Pract Rheumatol"},{"key":"8436_CR2","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.ajo.2004.03.022","volume":"138","author":"I Tugal-Tutkun","year":"2004","unstructured":"Tugal-Tutkun I, Onal S, Altan-Yaycioglu R, Huseyin Altunbas H, Urgancioglu M (2004) Uveitis in Beh\u00e7et disease: an analysis of 880 patients. Am J Ophthalmol 138:373\u2013380","journal-title":"Am J Ophthalmol"},{"key":"8436_CR3","doi-asserted-by":"crossref","first-page":"64","DOI":"10.3109\/09273948.2013.866257","volume":"22","author":"M Zierhut","year":"2014","unstructured":"Zierhut M, Abu El-Asrar AM, Bodaghi B, Tugal-Tutkun I (2014) Therapy of ocular Beh\u00e7et disease. Ocul Immunol Inflamm 22:64\u2013766","journal-title":"Ocul Immunol Inflamm"},{"key":"8436_CR4","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1093\/rheumatology\/keu233","volume":"53","author":"K Tascilar","year":"2014","unstructured":"Tascilar K, Melikoglu M, Ugurlu S, Sut N, Caglar E, Yazici H (2014) Vascular involvement in syndrome: a retrospective analysis of associations and the time course. Rheumatology (Oxford) 53:2018\u20132022","journal-title":"Rheumatology (Oxford)"},{"issue":"4 Suppl 84","key":"8436_CR5","first-page":"S99","volume":"32","author":"N Ambrose","year":"2014","unstructured":"Ambrose N, Pierce IT, Gatehouse PD, Haskard DO, Firmin DN (2014) Magnetic resonance imaging of vein wall thickness in patients with Beh\u00e7et\u2019s syndrome. Clin Exp Rheumatol 32(4 Suppl 84):S99\u2013S102","journal-title":"Clin Exp Rheumatol"},{"issue":"11","key":"8436_CR6","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1093\/rheumatology\/keq090","volume":"49","author":"P Mehta","year":"2010","unstructured":"Mehta P, Laffan M, Haskard DO (2010) Thrombosis and Beh\u00e7et\u2019s syndrome in non-endemic regions. Rheumatology (Oxford) 49(11):2003\u20132004","journal-title":"Rheumatology (Oxford)"},{"key":"8436_CR7","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1034\/j.1399-0039.1999.540301.x","volume":"54","author":"DH Verity","year":"1999","unstructured":"Verity DH, Marr JE, Ohno S, Wallace GR, Stanford MR (1999) Beh\u00e7et\u2019s disease, the Silk Road and HLA-B51: historical and geographical perspectives. Tissue Antigens 54:213\u2013220","journal-title":"Tissue Antigens"},{"key":"8436_CR8","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1093\/rheumatology\/ker428","volume":"51","author":"C Maldini","year":"2012","unstructured":"Maldini C, Lavalley MP, Cheminant M, de Menthon M, Mahr A (2012) Relationships of HLA-B51 or B5 genotype with Beh\u00e7et\u2019s disease clinical characteristics: systematic review and meta-analyses of observational studies. Rheumatology (Oxford) 51:887\u2013900","journal-title":"Rheumatology (Oxford)"},{"key":"8436_CR9","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1007\/s00296-015-3310-5","volume":"35","author":"N Ugurlu","year":"2015","unstructured":"Ugurlu N, Bozkurt S, Bacanli A, Akman-Karakas A, Uzun S, Alpsoy E (2015) The natural course and factors affecting severity of disease: a single center cohort of 368 patients. Rheum Int 35:2103\u20132107","journal-title":"Rheum Int"},{"key":"8436_CR10","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/S1474-4422(09)70015-8","volume":"8","author":"A Al-Araji","year":"2009","unstructured":"Al-Araji A, Kidd DP (2009) Neuro-Beh\u00e7et\u2019s disease: epidemiology, clinical characteristics and management. Lancet Neurol 8:192\u2013204","journal-title":"Lancet Neurol"},{"issue":"12","key":"8436_CR11","doi-asserted-by":"crossref","first-page":"3065","DOI":"10.1007\/s00415-013-7070-4","volume":"260","author":"DP Kidd","year":"2013","unstructured":"Kidd DP (2013) Optic neuropathy in Beh\u00e7et\u2019s syndrome. J Neurol 260(12):3065\u20133070","journal-title":"J Neurol"},{"key":"8436_CR12","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1212\/WNL.42.3.614","volume":"42","author":"B Wechsler","year":"1992","unstructured":"Wechsler B, Vidailhet M, Piette JC, Bousser MG, Dell Isola B, Bl\u00e9try O, Godeau P (1992) Cerebral venous thrombosis in Beh\u00e7et\u2019s disease: clinical study and long-term follow-up of 25 cases. Neurology 42:614\u2013618","journal-title":"Neurology"},{"key":"8436_CR13","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1007\/s00415-010-5885-9","volume":"258","author":"D Aguiar de Sousa","year":"2011","unstructured":"Aguiar de Sousa D, Mestre T, Ferro JM (2011) Cerebral venous thrombosis in Beh\u00e7et\u2019s disease: a systematic review. J Neurol 258:719\u2013727","journal-title":"J Neurol"},{"issue":"6","key":"8436_CR14","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1007\/s11910-012-0316-1","volume":"12","author":"D Kidd","year":"2012","unstructured":"Kidd D (2012) Neurological complications of Beh\u00e7et\u2019s syndrome. Curr Neurol Neurosci Rep 12(6):675\u2013679","journal-title":"Curr Neurol Neurosci Rep"},{"issue":"2","key":"8436_CR15","first-page":"55","volume":"16","author":"MG Hadfield","year":"1997","unstructured":"Hadfield MG, Aydin F, Lippman HR, Sanders KM (1997) Neuro-Beh\u00e7et\u2019s disease. Clin Neuropathol 16(2):55\u201360","journal-title":"Clin Neuropathol"},{"issue":"1\u20132","key":"8436_CR16","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jns.2007.09.041","volume":"267","author":"S Hirohata","year":"2008","unstructured":"Hirohata S (2008) Histopathology of central nervous system lesions in Beh\u00e7et\u2019s disease. J Neurol Sci 267(1\u20132):41\u201347","journal-title":"J Neurol Sci"},{"issue":"Pt 11","key":"8436_CR17","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1093\/brain\/122.11.2183","volume":"122","author":"D Kidd","year":"1999","unstructured":"Kidd D, Steuer A, Denman AM, Rudge P (1999) Neurological complications in Beh\u00e7et\u2019s syndrome. Brain 122(Pt 11):2183\u20132194","journal-title":"Brain"},{"issue":"Pt 11","key":"8436_CR18","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1093\/brain\/122.11.2171","volume":"122","author":"G Akman-Demir","year":"1999","unstructured":"Akman-Demir G, Serdaroglu P, Tas\u00e7i B (1999) Clinical patterns of neurological involvement in Beh\u00e7et\u2019s disease: evaluation of 200 patients. The Neuro-Beh\u00e7et Study Group. Brain 122(Pt 11):2171\u20132182","journal-title":"Brain"},{"issue":"2","key":"8436_CR19","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s004150170242","volume":"248","author":"A Siva","year":"2001","unstructured":"Siva A, Kantarci OH, Saip S, Altintas A, Hamuryudan V, Islak C, Ko\u00e7er N, Yazici H (2001) Beh\u00e7et\u2019s disease: diagnostic and prognostic aspects of neurological involvement. J Neurol 248(2):95\u2013103","journal-title":"J Neurol"},{"issue":"5","key":"8436_CR20","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1136\/jnnp.74.5.608","volume":"74","author":"A Al-Araji","year":"2003","unstructured":"Al-Araji A, Sharquie K, Al-Rawi Z (2003) Prevalence and patterns of neurological involvement in Beh\u00e7et\u2019s disease: a prospective study from Iraq. J Neurol Neurosurg Psychiatry 74(5):608\u2013613","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"6","key":"8436_CR21","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1007\/s00415-010-5454-2","volume":"257","author":"H Ideguchi","year":"2010","unstructured":"Ideguchi H, Suda A, Takeno M, Kirino Y, Ihata A, Ueda A, Ohno S, Baba Y, Kuroiwa Y, Ishigatsubo Y (2010) Neurological manifestations of Beh\u00e7et\u2019s disease in Japan: a study of 54 patients. J Neurol 257(6):1012\u20131020","journal-title":"J Neurol"},{"issue":"1","key":"8436_CR22","doi-asserted-by":"crossref","first-page":"34","DOI":"10.5152\/eurjrheum.2014.007","volume":"1","author":"N\u015e Bilge","year":"2014","unstructured":"Bilge N\u015e, \u015eayl\u0131soy S, Ka\u015fifoglu T, Korkmaz C (2014) Mass-like lesions as a rare form of neuro-Beh\u00e7et\u2019s disease: a case report and review of the literature. Eur J Rheumatol 1(1):34\u201338","journal-title":"Eur J Rheumatol"},{"key":"8436_CR23","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s004150050317","volume":"246","author":"O Oktem-Taner","year":"1999","unstructured":"Oktem-Taner O, Baskan-Kurt B, Gurvit H, Akman-Demir G, Serdaroglu P (1999) Neuropsychological follow up of 12 patients with Neuro-Beh\u00e7et disease. J Neurol 246:113\u2013119","journal-title":"J Neurol"},{"key":"8436_CR24","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.jns.2004.02.021","volume":"220","author":"R Monastero","year":"2004","unstructured":"Monastero R, Camardo C, Pipia L, Lopez G, Camarda L, Belmonte V, Ferrante A, Triolo C, Camarda R (2004) Cognitive impairment of Beh\u00e7et\u2019s disease patients without overt neurological involvement. J Neurol Sci 220:99\u2013104","journal-title":"J Neurol Sci"},{"key":"8436_CR25","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/j.1749-6632.2009.04670.x","volume":"1173","author":"S Covaco","year":"2009","unstructured":"Covaco S, da Silva AN, Pinto P, Continho E, Santos G, Bettencourt A, Pinto C, Goncalves A, Silva S, Gomes F, Corvalho L, Pereira C, Martins B, Correia J, Vasconcelos L (2009) Cognitive function in Beh\u00e7et\u2019s disease. Ann NY Acad Sci 1173:217\u2013226","journal-title":"Ann NY Acad Sci"},{"key":"8436_CR26","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1007\/s004060200008","volume":"252","author":"N Aydin","year":"2002","unstructured":"Aydin N, Aydin MD, Deniz O, Kirpinar I (2002) Neuro-Beh\u00e7et\u2019s disease involving the pons with initial onset of affective symptoms. Eur Arch Psychiatry Clin Neurosci 252:44\u201346","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"8436_CR27","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.clineuro.2009.07.009","volume":"111","author":"O Deniz","year":"2009","unstructured":"Deniz O, Caykoylu A, Vural G, Albayrak Y, Temel S, Aydin I, Kuloglu M (2009) A case study of neuro-psycho-Behcet\u2019s syndrome presenting with psychotic attack. Clin Neurol Neurosurg 111:87\u2013879","journal-title":"Clin Neurol Neurosurg"},{"key":"8436_CR28","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1177\/0883073813504137","volume":"29","author":"P Patel","year":"2014","unstructured":"Patel P, Steinschneider M, Bonaparth A, Lantos G (2014) Beh\u00e7et\u2019s disease presenting with acute psychosis in an adolescent. J Child Neurol 29:86\u201391","journal-title":"J Child Neurol"},{"key":"8436_CR29","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s40263-015-0228-0","volume":"29","author":"R Talerico","year":"2015","unstructured":"Talerico R, Palagini L, d\u2019Ascario D, Elefante E, Ferrari C, Stagnaro C, Tani C, Gemignani A, Mauri M, Bombardieri S, Mosca M (2015) Epidemiology and management of neuropsychiatric disorders in Beh\u00e7et\u2019s syndrome. CNS Drugs 29:189\u2013196","journal-title":"CNS Drugs"},{"key":"8436_CR30","doi-asserted-by":"publisher","DOI":"10.1111\/1756-185X.12839","author":"B Ilhan","year":"2016","unstructured":"Ilhan B, Can M, Alibaz-Oner F, Yilmaz-Oner S, Polat-Korkmaz O, Ozen G, Mumcu G, Haradit-Kremers H, Direskinlli H (2016) Fatigue in patients with Beh\u00e7et\u2019s syndrome: relationship with quality of life, depression, anxiety disability and disease activity. Int J Rheum Dis. doi:\n                        10.1111\/1756-185X.12839\n                        \n                     [Epub ahead of print]","journal-title":"Int J Rheum Dis"},{"issue":"1","key":"8436_CR31","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1006\/clin.1996.4268","volume":"82","author":"S Hirohata","year":"1997","unstructured":"Hirohata S, Isshi K, Oguchi H, Ohse T, Haraoka H, Takeuchi A, Hashimoto T (1997) Cerebrospinal fluid interleukin-6 in progressive Neuro-Beh\u00e7et\u2019s syndrome. Clin Immunol Immunopathol 82(1):12\u201317","journal-title":"Clin Immunol Immunopathol"},{"issue":"1\u20132","key":"8436_CR32","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.jneuroim.2003.08.040","volume":"145","author":"G Saruhan-Direskeneli","year":"2003","unstructured":"Saruhan-Direskeneli G, Yent\u00fcr SP, Akman-Demir G, I\u015fik N, Serdaro\u011flu P (2003) Cytokines and chemokines in neuro-Beh\u00e7et\u2019s disease compared to multiple sclerosis and other neurological diseases. J Neuroimmunol 145(1\u20132):127\u2013134","journal-title":"J Neuroimmunol"},{"issue":"7","key":"8436_CR33","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1111\/j.1526-4610.2005.05160.x","volume":"45","author":"S Saip","year":"2005","unstructured":"Saip S, Siva A, Altintas A, Kiyat A, Seyahi E, Hamuryudan V, Yazici H (2005) Headache in Beh\u00e7et\u2019s syndrome. Headache 45(7):911\u2013919","journal-title":"Headache"},{"issue":"5","key":"8436_CR34","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1093\/rheumatology\/kei255","volume":"45","author":"D Kidd","year":"2006","unstructured":"Kidd D (2006) The prevalence of headache in Beh\u00e7et\u2019s syndrome. Rheumatology (Oxford) 45(5):621\u2013623","journal-title":"Rheumatology (Oxford)"},{"issue":"2","key":"8436_CR35","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1111\/j.1468-2982.2005.01017.x","volume":"26","author":"E Aykutlu","year":"2006","unstructured":"Aykutlu E, Baykan B, Akman-Demir G, Topcular B, Ertas M (2006) Headache in Beh\u00e7et\u2019s disease. Cephalalgia 26(2):180\u2013186","journal-title":"Cephalalgia"},{"key":"8436_CR36","first-page":"1","volume":"19","author":"E Diwo","year":"2016","unstructured":"Diwo E, Gueudry J, Saadoun D, Weschler B, LeHoang P, Bodaghi B (2016) Long-term efficacy of interferon in severe uveitis associated with Beh\u00e7et disease. Ocul Immunol Inflamm 19:1\u20139","journal-title":"Ocul Immunol Inflamm"},{"issue":"10","key":"8436_CR37","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1016\/j.ophtha.2014.04.042","volume":"121","author":"M Takeuchi","year":"2014","unstructured":"Takeuchi M, Kezuka T, Sugita S, Keino H, Namba K, Kaburaki T, Maruyama K, Nakai K, Hijioka K, Shibuya E, Komae K, Hori J, Ohguro N, Sonoda KH, Mizuki N, Okada AA, Ishibashi T, Goto H, Mochizuki M (2014) Evaluation of the long-term efficacy and safety of infliximab treatment for uveitis in Beh\u00e7et\u2019s disease: a multicenter study. Ophthalmology 121(10):1877\u20131884","journal-title":"Ophthalmology"},{"key":"8436_CR38","first-page":"61","volume":"4","author":"A Atida","year":"2011","unstructured":"Atida A, Fragiadaki K, Giavri E, Sfikakis PP (2011) Anti-TNF agents for Beh\u00e7et\u2019s disease: analysis of published data on 369 patients. Semin Arthritis Rheum 4:61\u201370","journal-title":"Semin Arthritis Rheum"},{"key":"8436_CR39","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jaut.2015.06.005","volume":"62","author":"H Vallet","year":"2015","unstructured":"Vallet H, Riviere S, Sanna A, Deroux A, Moulis G, Addimanda O, Salvarani C, Lambert M, Bielefeld P, Seve P, Sibilia J, Pasquali J, Fraison J, Marie I, Perard L, Bouillet L, Cohen F, Sene D, Schoindre Y, Lidove O, Le Hoang P, Hachulla E, Fain O, Mariette X, Papo T, Wechsler B, Bodaghi B, Rigon MR, Cacoub P, Saadoun D, French Beh\u00e7et Network (2015) Efficacy of anti-TNF alpha in severe and\/or refractory Beh\u00e7et\u2019s disease: multicenter study of 124 patients. J Autoimmun 62:67\u201374","journal-title":"J Autoimmun"},{"key":"8436_CR40","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1080\/13543784.2016.1181751","volume":"25","author":"A Vitale","year":"2016","unstructured":"Vitale A, Rigante D, Lopalco G, Emmi G, Blanco MT, Galeazzi M, Iannone F, Cantarini L (2016) New therapeutic solutions for Beh\u00e7et\u2019s syndrome. Exp Opin Invest Drugs 25:827\u2013840","journal-title":"Exp Opin Invest Drugs"},{"key":"8436_CR41","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/art.23345","volume":"59","author":"N Pipitone","year":"2008","unstructured":"Pipitone N, Olivieri I, Padula A et al (2008) Infliximab for the treatment of Neuro-Beh\u00e7et\u2019s disease: a case series and review of the literature. Arthritis Rheum 59:285\u2013290","journal-title":"Arthritis Rheum"},{"key":"8436_CR42","doi-asserted-by":"crossref","first-page":"306","DOI":"10.3109\/s10165-008-0057-9","volume":"18","author":"S Sadreneddini","year":"2008","unstructured":"Sadreneddini S, Noshad H, Molaeefard M, Noshad R (2008) Treatment of retinal vasculitis in Beh\u00e7et\u2019s disease with Rituximab. Mod Rheumatol 18:306\u2013308","journal-title":"Mod Rheumatol"},{"issue":"12","key":"8436_CR43","doi-asserted-by":"crossref","first-page":"2676","DOI":"10.1007\/s00415-015-7897-y","volume":"262","author":"DP Kidd","year":"2015","unstructured":"Kidd DP (2015) Rituximab is effective in severe treatment-resistant neurological Beh\u00e7et\u2019s syndrome. J Neurol 262(12):2676\u20132677","journal-title":"J Neurol"},{"issue":"1","key":"8436_CR44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.autrev.2014.08.008","volume":"14","author":"L Cantarini","year":"2015","unstructured":"Cantarini L, Lopalco G, Caso F, Costa L, Iannone F, Lapadula G, Anelli MG, Franceschini R, Menicacci C, Galeazzi M, Selmi C, Rigante D (2015) Effectiveness and tuberculosis-related safety profile of interleukin-1 blocking agents in the management of Beh\u00e7et\u2019s disease. Autoimmun Rev 14(1):1\u20139","journal-title":"Autoimmun Rev"},{"issue":"4","key":"8436_CR45","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.semarthrit.2014.08.004","volume":"44","author":"O Adimanda","year":"2015","unstructured":"Adimanda O, Pipitone N, Pazzola G, Salvarani C (2015) Tocilizumab for severe refractory neuro-Beh\u00e7et: three cases IL-6 blockade in neuro-Beh\u00e7et. Semin Arthritis Rheum 44(4):472\u2013475","journal-title":"Semin Arthritis Rheum"},{"key":"8436_CR46","doi-asserted-by":"crossref","first-page":"107421","DOI":"10.1155\/2014\/107421","volume":"2014","author":"F Caso","year":"2014","unstructured":"Caso F, Costa L, Rigante D et al (2014) Biological treatments in Beh\u00e7et\u2019s disease: beyond anti-TNF therapy. Med Inflamm 2014:107421","journal-title":"Med Inflamm"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00415-017-8436-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-017-8436-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-017-8436-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,9,27]],"date-time":"2017-09-27T09:58:16Z","timestamp":1506506296000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00415-017-8436-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,10]]},"references-count":46,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2017,10]]}},"alternative-id":["8436"],"URL":"https:\/\/doi.org\/10.1007\/s00415-017-8436-9","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,10]]}}}